Oxidative stress and Post-stroke depression: Possible therapeutic role of polyphenols?

Current Medicinal Chemistry

Volumn 22, Issue 3, 2015, Pages 343-351

  Nabavi, Seyed Fazel ^a   Dean, Olivia M ^b,c,d   Turner, Alyna ^b,c,e   Sureda, Antoni ^f,g   Daglia, Maria ^h   Nabavi, Seyed Mohammad ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h UNIVERSITY OF PAVIA   (Italy)

Author keywords

Major depressive disorder; Oxidative stress; Polyphenols; Post stroke depression; Stroke

Indexed keywords

ANTIOXIDANT; NITRIC OXIDE; POLYPHENOL DERIVATIVE; POLYPHENOL;

ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; ENZYME METABOLISM; HUMAN; INFLAMMATION; LIPID PEROXIDATION; MAJOR DEPRESSION; MOLECULARLY TARGETED THERAPY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POST STROKE DEPRESSION; THERAPY EFFECT; VASCULAR ENDOTHELIUM; ANIMAL; DEPRESSION; DRUG EFFECTS; METABOLISM; PSYCHOLOGY;

ANIMALS; ANTIOXIDANTS; DEPRESSION; HUMANS; OXIDATIVE STRESS; POLYPHENOLS; STROKE;

EID: 84928686899     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867321666141106122319     Document Type: Article

References (124)

1. Vuković, V.; Mikula, I.; Kesić, M. J.; Bedeković, M. R.; Morović, S.; Lovrenčić-Huzjan, A.; Demarin, V. Perception of stroke in Croatia-knowledge of stroke signs and risk factors amongst neurological outpatients. Eur. J. Neurol., 2009, 16(9), 1060-1065.
2. Goetz, C. G. Textbook of clinical neurology. Elsevier Health Sciences, 2007.
3. Le, D. A.; Wu, Y.; Huang, Z.; Matsushita, K.; Plesnila, N.; Augustinack, J. C.; Hyman, B. T.; Yuan, J.; Kuida, K.; Flavell, R. A. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc. Natl. Acad. Sci. USA, 2002, 99(23), 15188-15193.
4. Lloyd-Jones, D.; Adams, R.; Carnethon, M.; De Simone, G.; Ferguson, T. B.; Flegal, K.; Ford, E.; Furie, K.; Go, A.; Greenlund, K. Heart disease and stroke statistics-2009 update a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2009, 119(3), e21-e181.
5. Niizuma, K.; Yoshioka, H.; Chen, H.; Kim, G. S.; Jung, J. E.; Katsu, M.; Okami, N.; Chan, P. H. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis., 2010, 1802(1), 92-99.
6. Niizuma, K.; Endo, H.; Chan, P. H. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J. Neurochem., 2009, 109(s1), 133-138.
7. Tobe, E. H. Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr. Dis. Treat., 2013, 9, 567-573.
8. Maes, M.; Galecki, P.; Chang, Y. S.; Berk, M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2011, 35(3), 676-692.
9. Berk, M.; Kapczinski, F.; Andreazza, A.; Dean, O.; Giorlando, F.; Maes, M.; Yücel, M.; Gama, C.; Dodd, S.; Dean, B. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav. Rev., 2011, 35(3), 804-817.
10. Ng, F.; Berk, M.; Dean, O.; Bush, A. I. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol., 2008, 11(06), 851-876.
11. Maes, M. An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2011, 35(3), 784-794.
12. Carota, A.; Berney, A.; Aybek, S.; Iaria, G.; Staub, F.; Ghika-Schmid, F.; Annable, L.; Guex, P.; Bogousslavsky, J. A prospective study of predictors of poststroke depression. Neurology, 2005, 64(3), 428-433.
13. Levenson, J. L. Cognitive Disorders After Stroke. Prim. psychiatry, 2007, 14(9), 37-40.
14. Nabavi, S.; Turner, A.; Dean, O.; Sureda, A.; Nabavi, S. Poststroke depression therapy: where are we now? Curr. Neurovasc. Res., 2014, 11(3), 279-289.
15. Hackett, M. L.; Pickles, K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int. J. Stroke, 2014, doi: 10.1111/ijs.12357.
16. Hadidi, N.; Treat-Jacobson, D. J.; Lindquist, R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung, 2009, 38(2), 151-162.
17. Allen, C.; Bayraktutan, U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J.stroke, 2009, 4(6), 461-470.
18. Chen, H.; Yoshioka, H.; Kim, G. S.; Jung, J. E.; Okami, N.; Sakata, H.; Maier, C. M.; Narasimhan, P.; Goeders, C. E.; Chan, P. H. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid. Redox. Signal., 2011, 14(8), 1505-1517.
19. Lee, W.-C.; Wong, H.-Y.; Chai, Y.-Y.; Shi, C.-W.; Amino, N.; Kikuchi, S.; Huang, S.-H. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? Biochem. Biophys. Res. Commun., 2012, 425(4), 842-847.
20. Osanai, T.; Fujiwara, N.; Sasaki, S.; Metoki, N.; Saitoh, G.; Tomita, H.; Nishimura, T.; Shibutani, S.; Yokoyama, H.; Konta, Y. Novel pro-atherogenic molecule coupling factor 6 is elevated in patients with stroke: a possible linkage to homocysteine. Ann. med., 2010, 42(1), 79-86.
21. Ventura, P.; Panini, R.; Verlato, C.; Scarpetta, G.; Salvioli, G. Peroxidation indices and total antioxidant capacity in plasma during hyperhomocysteinemia induced by methionine oral loading. Metabolism, 2000, 49(2), 225-228.
22. Faraci, F. M.; Lentz, S. R. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke, 2004, 35(2), 345-347.
23. Towfighi, A.; Markovic, D.; Ovbiagele, B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J. Neurol. Sci., 2010, 298(1), 153-157.
24. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA, 2002, 288(16), 2015-2022.
25. Cherubini, A.; Ruggiero, C.; Polidori, M. C.; Mecocci, P. Potential markers of oxidative stress in stroke. Free Radic. Biol. Med., 2005, 39(7), 841-852.
26. Domínguez, C.; Delgado, P.; Vilches, A.; Martín-Gallán, P.; Ribó, M.; Santamarina, E.; Molina, C.; Corbeto, N.; Rodríguez-Sureda, V.; Rosell, A. Oxidative stress after thrombolysis-induced reperfusion in human stroke. Stroke, 2010, 41(4), 653-660.
27. Kleinschnitz, C.; Grund, H.; Wingler, K.; Armitage, M. E.; Jones, E.; Mittal, M.; Barit, D.; Schwarz, T.; Geis, C.; Kraft, P. Poststroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS biol., 2010, 8(9), e1000479.
28. Amaro, S.; Chamorro, Á. Translational stroke research of the combination of thrombolysis and antioxidant therapy. Stroke, 2011, 42(5), 1495-1499.
29. Mizukoshi, G.; Katsura, K.-i.; Katayama, Y. Urinary 8-hydroxy-2'-deoxyguanosine and serum S100 β in acute cardioembolic stroke patients. Neurol. Res., 2005, 27(6), 644-646.
30. Kelly, P. J.; Morrow, J. D.; Ning, M.; Koroshetz, W.; Lo, E. H.; Terry, E.; Milne, G. L.; Hubbard, J.; Lee, H.; Stevenson, E. Oxida tive Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study. Stroke, 2008, 39(1), 100-104.
31. Wu, L.-J.; Wu, G.; Sharif, M. R. A.; Baker, A.; Jia, Y.; Fahey, F. H.; Luo, H. R.; Feener, E. P.; Clapham, D. E. The voltage-gated proton channel Hv1 enhances brain damage from ischemic stroke. Nat. Neurosci., 2012, 15(4), 565-573.
32. Chen, X.; Touyz, R. M.; Park, J. B.; Schiffrin, E. L. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in strokeprone SHR. Hypertension, 2001, 38(3), 606-611.
33. Dikalov, S. I.; Dikalova, A. E.; Bikineyeva, A. T.; Schmidt, H. H.; Harrison, D. G.; Griendling, K. K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic. Biol. Med., 2008, 45(9), 1340-1351.
34. Chrissobolis, S.; Faraci, F. M. The role of oxidative stress and NADPH oxidase in cerebrovascular disease. Trends Mol. Med., 2008, 14(11), 495-502.
35. Kawano, T.; Kunz, A.; Abe, T.; Girouard, H.; Anrather, J.; Zhou, P.; Iadecola, C. iNOS-derived NO and nox2-derived superoxide confer tolerance to excitotoxic brain injury through peroxynitrite. J. Cereb. Blood Flow Metab., 2007, 27(8), 1453-1462.
36. Faraci, F. M. Reactive oxygen species: influence on cerebral vascular tone. J. Appl. Physiol., 2006, 100(2), 739-743.
37. Hink, U.; Oelze, M.; Kolb, P.; Bachschmid, M.; Zou, M.-H.; Daiber, A.; Mollnau, H.; August, M.; Baldus, S.; Tsilimingas, N. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J. Am. Coll. Cardiol., 2003, 42(10), 1826-1834.
38. Iesaki, T.; Gupte, S. A.; Kaminski, P. M.; Wolin, M. S. Inhibition of guanylate cyclase stimulation by NO and bovine arterial relaxation to peroxynitrite and H2O2. Am. J. Physiol. Heart Circ. Physiol., 1999, 277(3), H978-H985.
39. Yamakura, F.; Taka, H.; Fujimura, T.; Murayama, K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J. Biol. Chem., 1998, 273(23), 14085-14089.
40. Eliasson, M. J.; Huang, Z.; Ferrante, R. J.; Sasamata, M.; Molliver, M. E.; Snyder, S. H.; Moskowitz, M. A. Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage. J. Neurosci., 1999, 19(14), 5910-5918.
41. Maria do Carmo, P. F.; Fortes, Z. B.; Akamine, E. H.; Kawamoto, E. M.; Scavone, C.; De Britto, L. R. G.; Muscara, M. N.; Teixeira, S. A.; Tostes, R. C.; Carvalho, M. H. C. Tetrahydrobiopterin improves endothelial dysfunction and vascular oxidative stress in microvessels of intrauterine undernourished rats. J. Physiol., 2004, 558(1), 239-248.
42. Mungrue, I. N.; Gros, R.; You, X.; Pirani, A.; Azad, A.; Csont, T.; Schulz, R.; Butany, J.; Stewart, D. J.; Husain, M. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J. Clin. Invest., 2002, 109(6), 735-743.
43. Pacher, P.; Szabo, C. Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease. Am. J. Pathol., 2008, 173(1), 2-13.
44. Crack, P. J.; Taylor, J. M. Reactive oxygen species and the modulation of stroke. Free Radic. Biol. Med., 2005, 38(11), 1433-1444.
45. Halterman, M. W.; Federoff, H. J. HIF-1β and p53 promote hypoxiainduced delayed neuronal death in models of CNS ischemia. Exp. Neurol., 1999, 159(1), 65-72.
46. Perez-Pinzon, M. A.; Dave, K. R.; Raval, A. P. Role of reactive oxygen species and protein kinase C in ischemic tolerance in the brain. Antioxid. Redox Signal., 2005, 7(9-10), 1150-1157.
47. Broughton, B. R.; Reutens, D. C.; Sobey, C. G. Apoptotic mechanisms after cerebral ischemia. Stroke, 2009, 40(5), e331-e339.
48. Crack, P. J.; Taylor, J. M.; Flentjar, N. J.; De Haan, J.; Hertzog, P.; Iannello, R. C.; Kola, I. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J. Neurochem., 2001, 78(6), 1389-1399.
49. Sasaki, T.; Shimizu, T.; Koyama, T.; Sakai, M.; Uchiyama, S.; Kawakami, S.; Noda, Y.; Shirasawa, T.; Kojima, S. Superoxide dismutase deficiency enhances superoxide levels in brain tissues during oxygenation and hypoxia-reoxygenation. J. Neurosci. Res., 2011, 89(4), 601-610.
50. Chan, P. H.; Kawase, M.; Murakami, K.; Chen, S. F.; Li, Y.; Calagui, B.; Reola, L.; Carlson, E.; Epstein, C. J. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci., 1998, 18(20), 8292-8299.
51. Kawase, M.; Murakami, K.; Fujimura, M.; Morita-Fujimura, Y.; Gasche, Y.; Kondo, T.; Scott, R. W.; Chan, P. H. Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency. Stroke, 1999, 30(9), 1962-1968.
52. Sugawara, T.; Noshita, N.; Lewén, A.; Gasche, Y.; Ferrand-Drake, M.; Fujimura, M.; Morita-Fujimura, Y.; Chan, P. H. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J. Neurosci., 2002, 22(1), 209-217.
53. D'Autréaux, B.; Toledano, M. B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol., 2007, 8(10), 813-824.
54. Huang, Z.; Huang, P. L.; Ma, J.; Meng, W.; Ayata, C.; Fishman, M. C.; Moskowitz, M. A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab., 1996, 16(5), 981-987.
55. Iadecola, C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci, 1997, 20(3), 132-139.
56. Yoshino, F.; Kobayashi, K. In Studies on Experimental Models; Springer, 2011, pp 91-103.
57. Alexandrova, M. L.; Bochev, P. G.; Markova, V. I.; Bechev, B. G.; Popova, M. A.; Danovska, M. P.; Simeonova, V. K. Changes in phagocyte activity in patients with ischaemic stroke. Luminescence, 2001, 16(6), 357-365.
58. de Carvalho Corrêa, M.; Maldonado, P.; Saydelles da Rosa, C.; Lunkes, G.; Lunkes, D. S.; Kaizer, R. R.; Ahmed, M.; Morsch, V. M.; Pereira, M. E.; Schetinger, M. R. Oxidative stress and erythrocyte acetylcholinesterase (AChE) in hypertensive and ischemic patients of both acute and chronic stages. Biomed. Pharmacother., 2008, 62(5), 317-324.
59. Swartz, C. M. Albumin decrement in depression and cholesterol decrement in mania. J. Affect. Disord., 1990, 19(3), 173-176.
60. Frasure-Smith, N.; Lespérance, F.; Julien, P. Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes. Biol. Psychiatry, 2004, 55(9), 891-896.
61. Gawryluk, J. W.; Wang, J.-F.; Andreazza, A. C.; Shao, L.; Young, L. T. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int. J. Neuropsychopharmacol., 2011, 14(01), 123-130.
62. Sarandol, A.; Sarandol, E.; Eker, S. S.; Erdinc, S.; Vatansever, E.; Kirli, S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Hum. Psychopharmacol., 2007, 22, (2), 67-73.
63. Forlenza, M. J.; Miller, G. E. Increased serum levels of 8-hydroxy-2'-deoxyguanosine in clinical depression. Psychosom. Med., 2006, 68(1), 1-7.
64. Yanik, M.; Erel, O.; Kati, M. The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr., 2004, 16(4), 200-203.
65. Selley, M. L. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression. J. Affect. Disord., 2004, 80(2), 249-256.
66. Cumurcu, B. E.; Ozyurt, H.; Etikan, I.; Demir, S.; Karlidag, R. Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin. Neurosci., 2009, 63(5), 639-645.
67. Chaudhari, K.; Khanzode, S.; Dakhale, G.; Saoji, A.; Sarode, S. Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder. Indian J. Clin. Biochem., 2010, 25(1), 77-81.
68. Michel, T. M.; Frangou, S.; Thiemeyer, D.; Camara, S.; Jecel, J.; Nara, K.; Brunklaus, A.; Zoechling, R.; Riederer, P. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder-a postmortem study. Psychiatry Res., 2007, 151(1), 145-150.
69. Gałecki, P.; Šmigielski, J.; Florkowski, A.; Bobińska, K.; Pietras, T.; Szemraj, J. Analysis of two polymorphisms of the manganese superoxide dismutase gene (Ile-58Thr and Ala-9Val) in patients with recurrent depressive disorder. Psychiatry Res., 2010, 179(1), 43-46.
70. Gałecki, P.; Florkowski, A.; Bobińska, K.; ͆migielski, J.; Bieńkiewicz, M.; Szemraj, J., Functional polymorphism of the myeloperoxidase gene (G-463A) in depressive patients. Acta Neuropsychiatr., 2010, 22(5), 218-222.
71. Owen, A.; Batterham, M.; Probst, Y.; Grenyer, B.; Tapsell, L. C. Low plasma vitamin E levels in major depression: diet or disease? Eur. J. Clin. Nutr., 2004, 59(2), 304-306.
72. Benkelfat, C.; Ellenbogen, M. A.; Dean, P.; Palmour, R. M.; Young, S. N. Mood-lowering effect of tryptophan depletion: enhanced susceptibility in young men at genetic risk for major affective disorders. Arch. Gen. Psychiatry, 1994, 51(9), 687-697.
73. Maes, M.; De Vos, N.; Demedts, P.; Wauters, A.; Neels, H. Lower serum zinc in major depression in relation to changes in serum acute phase proteins. J. Affect. Disord., 1999, 56(2), 189-194.
74. Maes, M.; Mihaylova, I.; Kubera, M.; Uytterhoeven, M.; Vrydags, N.; Bosmans, E., Lower plasma Coenzyme Q 10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinol. Lett., 2009, 30(4), 462-469.
75. Gibson, S. A.; Korade, Č.; Shelton, R. C. Oxidative stress and glutathione response in tissue cultures from persons with major depression. J. Psychiatr. Res., 2012, 46(10), 1326-1332.
76. Chrapko, W. E.; Jurasz, P.; Radomski, M. W.; Lara, N.; Archer, S. L.; Le Mellédo, J. M. Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder. Biol. Psychiatry, 2004, 56(2), 129-134.
77. Tsuboi, H.; Shimoi, K.; Kinae, N.; Oguni, I.; Hori, R.; Kobayashi, F. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J. Psychosom. Res., 2004, 56(1), 53-58.
78. Vargas, H. O.; Nunes, S. O. V.; de Castro, M. R. P.; Vargas, M. M.; Barbosa, D. S.; Bortolasci, C. C.; Venugopal, K.; Dodd, S.; Berk, M. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci. lett., 2013, 544, 136-140.
79. Khanzode, S. D.; Dakhale, G. N.; Khanzode, S. S.; Saoji, A.; Palasodkar, R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep., 2003, 8(6), 365-370.
80. Rawdin, B.; Mellon, S.; Dhabhar, F.; Epel, E.; Puterman, E.; Su, Y.; Burke, H.; Reus, V.; Rosser, R.; Hamilton, S. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav. Immun., 2013, 31, 143-152.
81. Maes, M.; Mihaylova, I.; Kubera, M.; Uytterhoeven, M.; Vrydags, N.; Bosmans, E. Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome. Neuro endocrinol. lett., 2008, 30(6), 715-722.
82. Maes, M.; Mihaylova, I.; Kubera, M.; Uytterhoeven, M.; Vrydags, N.; Bosmans, E. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J. Affect. Disord., 2010, 125(1), 287-294.
83. Michel, T. M.; Camara, S.; Tatschner, T.; Frangou, S.; Sheldrick, A. J.; Riederer, P.; Grünblatt, E. Increased xanthine oxidase in the thalamus and putamen in depression. World J. Biol. Psychiatry, 2010, 11(2-2), 314-320.
84. Sarandol, A.; Sarandol, E.; Eker, S. S.; Karaagac, E. U.; Hizli, B. Z.; Dirican, M.; Kirli, S. Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2006, 30(6), 1103-1108.
85. Nabavi, S. F.; Nabavi, S. M.; Habtemariam, S.; Moghaddam, A. H.; Sureda, A.; Jafari, M.; Latifi, A. M., Hepatoprotective effect of gallic acid isolated from Peltiphyllum peltatum against sodium fluorideinduced oxidative stress. Ind. Crops Prod., 2013, 44, 50-55.
86. Nabavi, S. F.; Daglia, M.; Moghaddam, A. H.; Habtemariam, S.; Nabavi, S. M. Curcumin and Liver Disease: from Chemistry to Medicine. Compr. Rev. Food Sci. Food Saf., 2014, 13(1), 62-77.
87. Hu, D.; Huang, J.; Wang, Y.; Zhang, D.; Qu, Y. Fruits and Vegetables Consumption and Risk of Stroke A Meta-Analysis of Prospective Cohort Studies. Stroke, 2014, 45(6), 1613-1619.
88. Larsson, S. C.; Virtamo, J.; Wolk, A. Total and specific fruit and vegetable consumption and risk of stroke: a prospective study. Atherosclerosis, 2013, 227(1), 147-152.
89. Joshipura, K. J.; Ascherio, A.; Manson, J. E.; Stampfer, M. J.; Rimm, E. B.; Speizer, F. E.; Hennekens, C. H.; Spiegelman, D.; Willett, W. C. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA, 1999, 282(13), 1233-1239.
90. Johnsen, S. P.; Overvad, K.; Stripp, C.; Tjønneland, A.; Husted, S. E.; Sørensen, H. T. Intake of fruit and vegetables and the risk of ischemic stroke in a cohort of Danish men and women. Am. J. Clin. Nutr., 2003, 78(1), 57-64.
91. Simonyi, A.; Wang, Q.; Miller, R. L.; Yusof, M.; Shelat, P. B.; Sun, A. Y.; Sun, G. Y. Polyphenols in cerebral ischemia. Mol. Neurobiol., 2005, 31(1-3), 135-147.
92. Nabavi, S.; Daglia, M.; Moghaddam, A.; Nabavi, S.; Curti, V. Tea Consumption and Risk of Ischemic Stroke: a Brief Review of the Literature. Curr. Pharm. Biotechnol., 2014, 15(4), 298-303.
93. Arab, L.; Liu, W.; Elashoff, D. Green and Black Tea Consumption and Risk of Stroke A Meta-Analysis. Stroke, 2009, 40(5), 1786-1792.
94. Shin, J. A.; Lee, H.; Lim, Y.-K.; Koh, Y.; Choi, J. H.; Park, E.-M. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J. Neuroimmunol., 2010, 227(1), 93-100.
95. Gao, D.; Zhang, X.; Jiang, X.; Peng, Y.; Huang, W.; Cheng, G.; Song, L. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci., 2006, 78(22), 2564-2570.
96. Lu, K. T.; Chiou, R. Y.; Chen, L. G.; Chen, M. H.; Tseng, W. T.; Hsieh, H. T.; Yang, Y. L. Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J. Agric Food Chem., 2006, 54(8), 3126-3131.
97. Tsai, S.-K.; Hung, L.-M.; Fu, Y.-T.; Cheng, H.; Nien, M.-W.; Liu, H.-Y.; Zhang, F. B.-Y.; Huang, S. S. Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J. Vasc. Surg., 2007, 46(2), 346-353.
98. Clark, D.; Tuor, U. I.; Thompson, R.; Institoris, A.; Kulynych, A.; Zhang, X.; Kinniburgh, D. W.; Bari, F.; Busija, D. W.; Barber, P. A. Protection against recurrent stroke with resveratrol: endothelial protection. PLoS One, 2012, 7(10), e47792.
99. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell, 2006, 127(6), 1109-1122.
100. Ritz, M.-F.; Curin, Y.; Mendelowitsch, A.; Andriantsitohaina, R. Acute treatment with red wine polyphenols protects from ischemiainduced excitotoxicity, energy failure and oxidative stress in rats. Brain Res., 2008, 1239, 226-234.
101. Ritz, M.-F.; Ratajczak, P.; Curin, Y.; Cam, E.; Mendelowitsch, A.; Pinet, F.; Andriantsitohaina, R. Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J. Nutr., 2008, 138(3), 519-525.
102. Mandel, S.; Weinreb, O.; Amit, T.; Youdim, M. B. Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J. Neurochem., 2004, 88(6), 1555-1569.
103. Singh, B. N.; Shankar, S.; Srivastava, R. K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol., 2011, 82(12), 1807-1821.
104. Liu, X.; Wang, Z.; Wang, P.; Yu, B.; Liu, Y.; Xue, Y. Green tea polyphenols alleviate early BBB damage during experimental focal cerebral ischemia through regulating tight junctions and PKCalpha signaling. BMC Complement. Altern. Med., 2013, 13(1), 187.
105. Maria, D.; Di Lorenzo, A.; Nabavi, S.; Talas, Z.; Nabavi, S. Gallic Acid and Related Compounds as Neuroprotective Agents: You are What ou Eat! Curr. Pharm. Biotechnol., 2014, 15(4), 362-372.
106. Perez-Vizcaino, F.; Duarte, J.; Andriantsitohaina, R. Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic. Res., 2006, 40(10), 1054-1065.
107. Bouayed, J. Polyphenols: a potential new strategy for the prevention and treatment of anxiety and depression. Curr. Nutr. Food Sci., 2010, 6(1), 13-18.
108. Dreiseitel, A.; Korte, G.; Schreier, P.; Oehme, A.; Locher, S.; Domani, M.; Hajak, G.; Sand, P. G. Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B. Pharmacol. Res., 2009, 59(5), 306-311.
109. Niu, K.; Hozawa, A.; Kuriyama, S.; Ebihara, S.; Guo, H.; Nakaya, N.; Ohmori-Matsuda, K.; Takahashi, H.; Masamune, Y.; Asada, M. Green tea consumption is associated with depressive symptoms in the elderly. Am. J. Clin. Nutr., 2009, 90(6), 1615-1622.
110. Zhu, W.-L.; Shi, H.-S.; Wei, Y.-M.; Wang, S.-J.; Sun, C.-Y.; Ding, Z.-B.; Lu, L. Green tea polyphenols produce antidepressant-like effects in adult mice. Pharmacol. Res., 2012, 65(1), 74-80.
111. Sattayasai, J.; Tiamkao, S.; Puapairoj, P., Biphasic effects of Morus alba leaves green tea extract on mice in chronic forced swimming model. Phytother. Res., 2008, 22(4), 487-492.
112. Vignes, M.; Maurice, T.; Lanté, F.; Nedjar, M.; Thethi, K.; Guiramand, J.; Récasens, M., Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG). Brain Res., 2006, 1110(1), 102-115.
113. Pase, M. P.; Scholey, A. B.; Pipingas, A.; Kras, M.; Nolidin, K.; Gibbs, A.; Wesnes, K.; Stough, C. Cocoa polyphenols enhance positive mood states but not cognitive performance: a randomized, placebo-controlled trial. J. Psychopharmacol., 2013, 27(5), 451-458.
114. Messaoudi, M.; Bisson, J.-F.; Nejdi, A.; Rozan, P.; Javelot, H., Antidepressant-like effects of a cocoa polyphenolic extract in Wistar-Unilever rats. Nutr. Neurosci., 2008, 11(6), 269-276.
115. Sathyapalan, T.; Beckett, S.; Rigby, A. S.; Mellor, D. D.; Atkin, S. L. High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr. J., 2010, 9(1), 55.
116. Yáñez, M.; Fraiz, N.; Cano, E.; Orallo, F. Inhibitory effects of cisand trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity. Biochem. Biophys. Res. Commun., 2006, 344(2), 688-695.
117. Xu, Y.; Wang, Z.; You, W.; Zhang, X.; Li, S.; Barish, P. A.; Vernon, M. M.; Du, X.; Li, G.; Pan, J. Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system. Eur. Neuropsychopharmacol., 2010, 20, (6), 405-413.
118. Yu, Y.; Wang, R.; Chen, C.; Du, X.; Ruan, L.; Sun, J.; Li, J.; Zhang, L.; O'Donnell, J. M.; Pan, J. Antidepressant-like effect of trans-resveratrol in chronic stress model: Behavioral and neurochemical evidences. J. Psychiatric Res., 2013, 47(3), 315-322.
119. Dias, G. P.; Cavegn, N.; Nix, A.; do Nascimento Bevilaqua, M. C.; Stangl, D.; Zainuddin, M. S. A.; Nardi, A. E.; Gardino, P. F.; Thuret, S. The role of dietary polyphenols on adult hippocampal neurogenesis: molecular mechanisms and behavioural effects on depression and anxiety. Oxid. Med. Cell Longev., 2012, 2012.
120. Zainuddin, M. S. A.; Thuret, S. Nutrition, adult hippocampal neurogenesis and mental health. Brit. Med. Bull., 2012, 103(1), 89-114.
121. Liu, M.; Jiang, Q. H.; Hao, J. L.; Zhou, L. L., Protective effect of total flavones of Abelmoschus manihot L. Medic against poststroke depression injury in mice and its action mechanism. Anat. Rec., 2009, 292(3), 412-422.
122. Lan, J.; Yan, B.; Zhao, Y.n.; Wang, D.; Hu, J.; Xing, D.; Du, L. Cerebral ischemia reperfusion exacerbates and pueraria flavonoids attenuate depressive responses to stress in mice. Tsinghua Sci. Technol., 2008, 13(4), 485-491.
123. Yan, B.; Wang, D. Y.; Xing, D.-M.; Ding, Y.; Wang, R. F.; Lei, F.; Du, L. J. The antidepressant effect of ethanol extract of radix puerariae in mice exposed to cerebral ischemia reperfusion. Pharmacol. Biochem. Behav., 2004, 78(2), 319-325.
124. Aggarwal, A.; Gaur, V.; Kumar, A. Nitric oxide mechanism in the protective effect of naringin against post-stroke depression (PSD) in mice. Life Sci., 2010, 86(25), 928-935.